Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer. Chiec L, Shah AN. Semin Oncol 2020 Aug 20. pii: S0093-7754(20)30084.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chiec L, Shah AN. Risk-based Approaches for Optimizing Treatment in HER2-Positive Early Stage Breast Cancer. Semin Oncol 2020 Aug 20. pii: S0093-7754(20)30084.
PMID: 32928586